Two 2026 papers test the protein advice older adults keep getting. Neither result is clean
A NHANES analysis of 5,736 US adults over 60 found the benefit of higher protein directionally present and statistically imprecise. A meta-analysis of protein at breakfast found nothing at all.
Two claims travel together in consumer nutrition advice for older adults: eat more protein than the official recommendation, and spread it across the day rather than loading it at dinner. Two papers published this year test them separately. Neither returns the clean answer the advice implies.
The intake question
An analysis published in the Journal of the International Society of Sports Nutrition on 14 April used a target-trial emulation framework — a method that structures observational data to mimic the design of a randomised trial — on four NHANES survey cycles from 2011 to 2018, covering 5,736 US adults aged 60 and over with complete exposure, outcome and covariate data [s1].
Usual protein intake in grams per kilogram of body weight per day was derived from available 24-hour dietary recalls [s1]. The primary outcome was mobility limitation as defined by the survey's physical functioning questionnaire; grip strength, available for the 2011-2014 cycles, was analysed separately as a secondary outcome [s1].
The starting numbers are the ones most worth knowing. Mean usual protein intake among these adults was 0.93 g/kg/day, and approximately 42% consumed at least 0.8 g/kg/day — the current Recommended Dietary Allowance for the general adult population [s1].
That is the context the "eat more protein" message enters. The majority of older US adults in this sample were not at the baseline recommendation, let alone above it.
What higher intake was associated with
The analysis compared predefined intake categories — under 0.8, 0.8 to under 1.0, 1.0 to under 1.2, and 1.2 or more g/kg/day — using covariate-balancing propensity score overlap weighting followed by marginal structural models, with doubly robust sensitivity analyses [s1].
Higher intake was associated with lower odds of mobility limitation, but the primary contrast — 1.2 or more against under 0.8 g/kg/day — was modest and not statistically significant, at an odds ratio of 0.89 (95% CI 0.54-1.47) [s1]. A doubly robust binary contrast produced a difference of -6.6 percentage points in predicted limitation, with a confidence interval running from -25.8 to 12.7 [s1] — consistent in direction, and imprecise enough to include a substantial harm.
One sub-result was significant: in the 2015-2018 cycles analysed separately, the inverse association reached an odds ratio of 0.80 (95% CI 0.65-0.98) [s1]. A finding that appears in one half of a dataset and not the other is a hypothesis, not a conclusion.
The more useful output is the shape rather than the contrast. Spline models suggested a steeper decline in predicted limitation below approximately 1.0-1.1 g/kg/day, with a flatter trajectory at higher intakes [s1]. If that shape is real, it implies the returns are concentrated in getting people from low intake up toward roughly 1 g/kg/day, and that pushing beyond it adds little.
The authors are direct about the limits. The exploratory mediation models suggesting an indirect component through the inflammatory marker hs-CRP were not overlap-weighted and should be interpreted cautiously [s1]. And given the cross-sectional design and residual potential for confounding, they state the findings should be interpreted cautiously overall, with prospective studies needed to determine whether sustained intake in this range meaningfully preserves functional capacity [s1].
The timing question
The second claim — that protein should be redistributed toward breakfast — got a stricter test. A systematic review and meta-analysis published in Food Science & Nutrition on 24 July pooled randomised controlled trials comparing morning protein intake against no morning intake in healthy and frail adults aged 60 and over, with searches of MEDLINE, CENTRAL, EMBASE and ClinicalTrials.gov developed by a trained librarian, and risk of bias assessed with the Cochrane tool [s2].
Seven randomised trials involving 305 participants met the criteria [s2]. The results across outcomes:
- Lean mass, from 5 studies (n = 181): standardised mean difference -0.11 (95% CI -0.41 to 0.18) [s2]
- Grip strength, from 6 studies (n = 274): SMD -0.01 (95% CI -0.25 to 0.23) [s2]
- Lower limb strength, from 3 studies (n = 157): SMD -0.11 (95% CI -0.41 to 0.18) [s2]
All three intervals straddle zero, and all three point estimates sit at or slightly below it.
There was one directional finding, and it runs against the intervention: morning protein intake produced a marginal reduction in total daily energy intake (SMD -0.35, 95% CI -0.70 to 0.00), which became significant in trials without an exercise component (SMD -0.47, 95% CI -0.82 to -0.11) [s2]. Protein is filling; eating more of it at breakfast appears to have displaced other food later.
The authors conclude that morning protein intake may not improve muscle mass, strength or physical performance in older adults and may slightly reduce food intake without exercise — while stating that the evidence is very uncertain and calling for further high-quality trials [s2]. Seven trials and 305 participants is a thin base, and "very uncertain" is the authors' own grading.
Reading the two together
Neither paper says protein does not matter. The NHANES analysis found the association pointing in the expected direction throughout, and identified a plausible range — around 1.0-1.1 g/kg/day — where the relationship with mobility limitation is steepest [s1]. What it did not find was statistical support for the specific claim that intakes at or above 1.2 g/kg/day are better than lower ones.
And the timing meta-analysis found no muscle benefit from moving protein to breakfast while holding daily intake constant [s2] — which is the version of the redistribution claim that consumer advice usually makes.
The gap between the two literatures and the marketing is not that the marketing is inventing effects. It is that the marketing states as settled what the papers state as directional, imprecise, or absent.
What to watch
Whether a prospective study follows sustained protein intake and functional outcomes over years rather than inferring from cross-sectional recalls, which is what the NHANES authors call for [s1]. And whether the protein-timing literature grows past seven small trials, since a body of evidence that size cannot rule out a modest effect any more than it can demonstrate one.
Sources
- [s1] Association between usual protein intake and muscle function in older U.S. adults: a target-trial emulation using NHANES 2011-2018. Journal of the International Society of Sports Nutrition, published online 14 April 2026. https://doi.org/10.1080/15502783.2026.2658171
- [s2] Protein or Amino Acid Intake at Breakfast for Muscle Mass Gain in Older Adults: A Systematic Review and Meta-Analysis. Food Science & Nutrition, published online 24 July 2026. https://doi.org/10.1002/fsn3.72171
Sources
- Association between usual protein intake and muscle function in older U.S. adults: a target-trial emulation using NHANES 2011-2018 — Journal of the International Society of Sports Nutrition , April 14, 2026
- Protein or Amino Acid Intake at Breakfast for Muscle Mass Gain in Older Adults: A Systematic Review and Meta-Analysis — Food Science & Nutrition , July 24, 2026
More on
Age-related muscle loss is now a diagnosable disease. One treatment has strong backing.
Sarcopenia got a formal definition and diagnostic cut-offs. The clinical guidelines that followed back resistance exercise strongly — and are far more cautious about protein powders, vitamin D and drugs.
Two October papers on creatine in older adults point at strength, not muscle mass
A meta-analysis of 20 trials found a two-kilogram gain in one-rep max and no effect on bone density. A small crossover trial found functional strength gains largely independent of muscle mass.
Weekend-only exercise tracked the same lower disease risk as spreading it out
Across 89,573 accelerometer-monitored adults and 678 conditions, no disease showed a significant difference between activity concentrated in one or two days and activity spread through the week.
Alkaline water is marketed for muscle recovery in older adults. Nobody has tested it.
A review of two decades of research found ten studies on alkaline water and muscle outcomes — and every single one excluded adults over 65, the exact population the marketing targets.